Scopolamine for cancer-related nausea and vomiting.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 20619216.
- Also identified by DOI 10.1016/j.jpainsymman.2009.12.008.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Nausea and vomiting is a common and troublesome symptom in advanced cancer. There have been different approaches described for the management of nausea and vomiting, specifically empirical and etiological. Scopolamine is listed in textbooks as a useful medication in management of nausea and vomiting in this setting, although there is no published data to support this recommendation. We present three cases that support the use of scopolamine in an etiologically based approach for management of nausea in advanced cancer.
Medical subject headings
- Antiemetics
- Antineoplastic Agents
- Nausea
- Neoplasms
- Scopolamine
- Vomiting